Huaren Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Huaren Pharmaceutical Co Ltd cash flow-to-debt ratio. Huaren Pharmaceutical Co Ltd (300110) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥86.78 Million could theoretically repay 0% of its total liabilities (CN¥1.97 Billion) in one year. Check 300110 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Huaren Pharmaceutical Co Ltd (2007–2025)
Cash flow-to-debt ratio of Huaren Pharmaceutical Co Ltd from 2007 to 2025. Historical debt coverage capacity for Huaren Pharmaceutical Co Ltd across 19 annual periods. Check total reinvestment intensity of Huaren Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Huaren Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Huaren Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Huaren Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 300110 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥390.23 Million | CN¥1.79 Billion | ▲ +38.7% |
| 2024 | 0.16x | CN¥322.36 Million | CN¥2.05 Billion | ▲ +23.2% |
| 2023 | 0.13x | CN¥305.60 Million | CN¥2.40 Billion | ▲ +49.7% |
| 2022 | 0.09x | CN¥217.98 Million | CN¥2.56 Billion | ▲ +147.0% |
| 2021 | -0.18x | CN¥-578.52 Million | CN¥3.20 Billion | ▼ -1729.0% |
| 2020 | -0.01x | CN¥-10.74 Million | CN¥1.09 Billion | ▼ -101.5% |
| 2019 | 0.67x | CN¥309.33 Million | CN¥461.81 Million | ▲ +136.3% |
| 2018 | 0.28x | CN¥254.32 Million | CN¥897.11 Million | ▲ +79.8% |
| 2017 | 0.16x | CN¥211.08 Million | CN¥1.34 Billion | ▲ +4.1% |
| 2016 | 0.15x | CN¥181.65 Million | CN¥1.20 Billion | ▲ +956.6% |
| 2015 | 0.01x | CN¥18.77 Million | CN¥1.31 Billion | ▼ -75.0% |
| 2014 | 0.06x | CN¥65.56 Million | CN¥1.14 Billion | ▲ +31.0% |
| 2013 | 0.04x | CN¥39.78 Million | CN¥907.56 Million | ▼ -80.4% |
| 2012 | 0.22x | CN¥99.44 Million | CN¥445.69 Million | ▼ -79.1% |
| 2011 | 1.07x | CN¥59.53 Million | CN¥55.77 Million | ▼ -34.5% |
| 2010 | 1.63x | CN¥77.61 Million | CN¥47.60 Million | ▲ +1259.2% |
| 2009 | 0.12x | CN¥38.63 Million | CN¥321.98 Million | ▼ -40.0% |
| 2008 | 0.20x | CN¥57.24 Million | CN¥286.30 Million | ▲ +363.3% |
| 2007 | 0.04x | CN¥7.66 Million | CN¥177.50 Million | — |